Key result
Aerobic exercise inhibits pressure-overload myocardial fibrosis by downregulating USP22 and destabilizing BRD4 in mice.
Why the study?
Aerobic exercise can counteract pathological myocardial fibrosis, but the underlying regulatory mechanism remains unclear, particularly whether exercise acts by regulating the USP22-BRD4 signaling pathway during pressure overload.
Does aerobic exercise reduce pressure-overload-induced myocardial fibrosis and improve cardiac function by inhibiting the USP22-BRD4 signaling pathway in a mouse model of pressure overload?
Does aerobic exercise reduce pressure-overload-induced myocardial fibrosis and improve cardiac function by inhibiting the USP22-BRD4 signaling pathway in a mouse model of pressure overload?
This preclinical study identifies the USP22-BRD4 signaling axis as a molecular mechanism by which aerobic exercise attenuates pressure-overload-induced myocardial fibrosis, offering a potential therapeutic target for heart failure.
Answers are grounded in this paper and cite their sources.
Does not support clinical adoption of USP22-BRD4 targeting; leaves open its role in human pressure-overload fibrosis.
Pathological myocardial fibrosis is the core pathological process by which excessive stress induces myocardial remodeling and eventually leads to heart failure. Aerobic exercise, as an effective non‐pharmacological intervention method, can counteract myocardial fibrosis. However, the underlying regulatory mechanism remains unclear. The deubiquitinating enzyme USP22 is widely involved in the pathological processes of various cardiovascular diseases. This study aims to investigate whether aerobic exercise can improve myocardial fibrosis induced by stress overload by regulating the USP22‐BRD4 signaling pathway. A transverse aortic constriction (TAC) mouse model of pressure overload was constructed In vivo, and combined with aerobic exercise intervention and AAV9‐USP22 overexpression intervention. Survival rate analysis, cardiac ultrasound, histopathological staining, and molecular detection results confirmed that pressure overload can induce high expression of USP22 in cardiac fibroblasts. Aerobic exercise can inhibit USP22‐mediated myocardial fibrosis, improve cardiac function, and overexpression of USP22 can counteract the cardiac protective effect brought by exercise. In vitro, primary cardiac fibroblasts were stimulated with TGF‐β, and silencing of USP22 significantly inhibited fibroblast migration, myofibroblast transformation, and the expression of fibrosis markers such as fibronectin, collagen I, collagen III, and α‐SMA. Overexpression of USP22 further amplified the pro‐fibrotic phenotype. At the mechanism level, USP22 interacts with BRD4 at the protein level and increases the stability of BRD4 protein through deubiquitination modification; rescue experiments confirmed that BRD4 is the downstream effector molecule of USP22 in promoting fibrosis. In conclusion, aerobic exercise downregulates USP22 expression, reduces the stability of BRD4 protein, and thereby inhibits the activation of cardiac fibroblasts and myocardial interstitial fibrosis. The USP22‐BRD4 regulatory axis can serve as a potential intervention target for pressure overload‐induced heart failure and provide a new molecular theoretical basis for clinical cardiac rehabilitation exercise programs.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2026) studied Pressure-overload-induced myocardial fibrosis and heart failure. Aerobic exercise (combined with AAV9-USP22 overexpression or USP22 silencing) vs. Pressure overload (TAC) without aerobic exercise or with USP22 overexpression was evaluated on Myocardial interstitial fibrosis, cardiac function, and cardiac fibroblast activation via the USP22-BRD4 pathway. Aerobic exercise downregulates USP22 expression and destabilizes BRD4 protein via ubiquitination, thereby inhibiting cardiac fibroblast activation and pressure-overload myocardial fibrosis in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: